Tredje AP-fonden’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
76,465
+25,290
| +49% | +$911K | 0.02% | 185 |
|
|
2025
Q1 | $1.59M | Hold |
51,175
| – | – | 0.01% | 266 |
|
|
2024
Q4 | $1.31M | Sell |
51,175
-51,175
| -50% | -$1.31M | 0.01% | 349 |
|
|
2024
Q3 | $2.9M | Hold |
102,350
| – | – | 0.03% | 298 |
|
|
2024
Q2 | $2.7M | Sell |
102,350
-20,841
| -17% | -$550K | 0.03% | 294 |
|
|
2024
Q1 | $3.74M | Buy |
123,191
+14,785
| +14% | +$449K | 0.04% | 243 |
|
|
2023
Q4 | $3.05M | Hold |
108,406
| – | – | 0.04% | 286 |
|
|
2023
Q3 | $2.94M | Sell |
108,406
-3,647
| -3% | -$99K | 0.04% | 267 |
|
|
2023
Q2 | $3.44M | Sell |
112,053
-6,988
| -6% | -$215K | 0.05% | 261 |
|
|
2023
Q1 | $4.29M | Buy |
119,041
+48,345
| +68% | +$1.74M | 0.07% | 213 |
|
|
2022
Q4 | $2.79M | Buy |
70,696
+1,971
| +3% | +$77.9K | 0.05% | 293 |
|
|
2022
Q3 | $2.76M | Buy |
+68,725
| New | +$2.76M | 0.06% | 255 |
|